Why Your Own GLP-1 Seems to Stop Working

August 1, 2026 · Last reviewed August 8, 2026

Written and reviewed by Rev. Dr. LaVeena B. Archers, PhD
Doctor of Natural Medicine · Board-certified in Holistic Functional Medicine and Functional Nutrition
Educational content only. Not medical advice, and never a substitute for your own care. Scope of practice.

The women who write to me often describe the same change. They did everything right for years, and somewhere in their forties the fullness that used to arrive after a meal stopped arriving. Hunger came back sooner. The old habits stopped holding their weight. Many of them ask the same question: has my own GLP-1 stopped working?

It is a fair question, and the honest answer surprises people. GLP-1 very rarely breaks. The better question is whether it has gone quiet, and the honest answer to that one is: possibly, in ways worth understanding. (Here is what GLP-1 actually does, if you want the primer first.)

Did your GLP-1 break, or just go quiet?

Your body still makes GLP-1 after meals. Whether some bodies come to make less of it is genuinely contested. A large Danish study of nearly 1,500 adults found that people with overweight or obesity had up to 20 percent lower GLP-1 response to an oral glucose drink ^[1], while a meta-analysis of 22 clinical studies found no consistent difference in GLP-1 secretion between people with and without type 2 diabetes ^[2]. A major review of the field describes this as an open controversy ^[3], and I will not pretend to settle it for you here.

What is not in dispute is that the signal still works when it arrives. When GLP-1 is given by infusion, people with overweight cut their food intake by about the same proportion as lean people do ^[4]. And the drugs built on this hormone work remarkably well in exactly the people whose own signal is supposed to have failed ^[5]. So if something has changed for you, the better-supported version is a somewhat weaker signal, not a brain that has stopped listening. That difference matters, because a weaker signal has levers.

Why the signal can run quieter

There are five candidate reasons, and they can stack. I will tell you plainly which are established and which are still hypotheses.

Where the signal comes from. Much of your GLP-1 comes from cells low in the small intestine and the colon, and their density rises the further down the gut you go ^[6]. Nutrients reaching the lower small intestine suppress appetite more strongly than the same nutrients higher up, at least at modest amounts, the so-called intestinal brake, and GLP-1 is part of that mechanism ^{[7, 8]}. Whether ultra-processed food short-circuits this by being absorbed higher up has not been directly tested, and I want to be careful not to claim it has. What has been tested is the outcome: in a tightly controlled inpatient trial, with both diets matched for calories, fiber, sugar and fat, people ate about 500 calories a day more on the ultra-processed diet, ate faster, and had lower levels of the fullness hormone PYY, a partner hormone made largely by the same gut cells ^{[9, 6]}.

A starved gut. The bacteria in your lower gut ferment fiber into short-chain fatty acids, and in animal studies those are one of the things that prompt the cells there to release GLP-1 and PYY ^[10]. A diet low in fiber starves those bacteria. Whether a quieter gut community means a quieter hormone in humans has not been nailed down, and I still think fiber is the most sensible piece to work on, because its other benefits are not in question.

Blood sugar on a roller coaster. When a meal sends blood sugar up and then down, the dip itself tracks with what happens next. Across more than a thousand people wearing continuous glucose monitors, bigger dips two to three hours after a meal predicted more hunger, a shorter wait until the next meal, and more calories eaten across the following day ^[11]. The associations are modest, and they all point the same direction. Steadier blood sugar is worth having on its own terms.

Short sleep and a nervous system stuck on. Short sleep genuinely raises the drive to eat. Across 41 randomized trials, restricting sleep increased hunger, led people to eat roughly 250 more calories a day, and changed how the brain's reward regions responded to food. What those same trials did not find was a consistent shift in the appetite hormones you have probably read about, leptin and ghrelin. The behavior story is stronger than the hormone story, and I would rather tell you the true version ^[12]. Stress pushes in the same direction, gently: pooled across 54 studies, it nudged intake up only slightly, shifting people toward less healthy food more than toward simply more food ^[13]. None of this is about willpower.

Falling estrogen, in midlife. Here I want to be careful about what is actually known. In female animals, estrogen appears to sharpen the brain's response to GLP-1: in one study, the same central dose of GLP-1 curbed food intake more readily in rats given estradiol than in those without it ^[14]. Whether that carries over into women has not been shown. If it does, the drop in estrogen through perimenopause could leave your own GLP-1 a little less able to quiet appetite, in the very season when appetite already feels harder to read. I offer that as a plausible piece of the puzzle, not a settled fact.

What the drugs actually do

This is where the medicines fit. Semaglutide is a long-acting version of the GLP-1 signal ^[15]; tirzepatide acts on the GLP-1 receptor and on the receptor for a second gut hormone, GIP ^[16]. Neither addresses the conditions above. What they do is hold a signal on for far longer than your own gut ever could: your own GLP-1 is broken down within minutes, so fast that much of it is inactivated before it even leaves the gut wall ^[7], while semaglutide has a half-life of about a week ^[17]. Not a louder shout so much as a signal that never stops.

That steady signal is largely independent of what your food, your gut, or your sleep are doing, which is why the drugs can work even when habits have not changed. It is also consistent with what happens when people stop. In the STEP 1 extension, participants regained about two-thirds of their lost weight in the year after both semaglutide and the trial's lifestyle support ended ^[18]. In a second trial, four-fifths of them women, those switched to placebo at week 20 steadily regained while those who continued kept losing ^[19]. For some women, especially those carrying real health risk, that steady signal is a legitimate and useful tool, and any decision about it belongs with your own prescriber.

Turning your own signal back up

If your signal is quieter than it was, the levers are ordinary ones. I will not promise they raise GLP-1 the way a drug does, because nobody has shown that. What they reliably do is support the system this hormone lives in, and every one of them is worth doing on its own terms:

• Protein and fiber at every meal, both of which stimulate GLP-1 release ^[20]
• Whole food over ultra-processed, the swap that cut intake by about 500 calories a day in the inpatient trial ^[9]
• A well-fed gut community, tended with fiber and fermented foods; in one small trial, fermented foods increased gut-community diversity, though GLP-1 itself was not measured ^[21]
• Steadier blood sugar, worth having in its own right ^[11]; building meals around protein, fiber, and fat rather than fast carbohydrates is how I get there in practice
• Movement most days, plus strength work; in trials of older adults losing weight, it prevented most of the muscle they would otherwise have lost ^[22]
• Sleep treated as real work rather than a luxury, because short sleep reliably raises the drive to eat ^[12]

Start from the more likely truth

So the next time you wonder whether your own GLP-1 has quit, start from what the evidence actually supports. It is still there. It may be somewhat quieter than it once was, and the science on that is genuinely unsettled. The habits above are the ones with a real case behind them, whatever this one hormone turns out to be doing. And the supplements sold as "nature's Ozempic" are not on that list.

I am writing a whole book around this question. Your Body's Own GLP-1 walks through why the signal may fade, what the drugs do and what they cost, and how to support your own, with every claim marked for how strong the evidence behind it is. Join the reader list to hear when it arrives.

If you want the wider root-cause picture of women's health first, the opening chapter of Bad Medicine Blues is free. Read a free chapter.

← All posts